• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectrometry.

作者信息

Parnetti L, Gottfries J, Karlsson I, Långström G, Gottfries C G, Svennerholm L

出版信息

Acta Psychiatr Scand. 1987 May;75(5):542-8. doi: 10.1111/j.1600-0447.1987.tb02831.x.

DOI:10.1111/j.1600-0447.1987.tb02831.x
PMID:2440238
Abstract

Monoamines and their main metabolites were measured using HPLC-EC in the cerebrospinal fluid from age-matched elderly in-patients affected with senile dementia of Alzheimer type and chronic schizophrenia. Determination of the monoamine metabolites MHPG, HVA and 5-HIAA was also performed by means of gas chromatography-mass spectrometry. Significant differences were obtained with the two methods, the largest deviation being found for HVA, which was 15% higher in the HPLC method than in the GC-MS method, despite the correlation between the results of two measurements being consistent for all the three metabolites. The degrees of motor, intellectual and emotional deterioration were assessed using GBS rating scale. The results show a clear psychobehavioral and neurochemical differentiation of the two patient groups. HVA and 5-HIAA levels were significantly lower in SDAT patients, and showed a trend toward negative correlation with the degree of dementia.

摘要

相似文献

1
Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectrometry.
Acta Psychiatr Scand. 1987 May;75(5):542-8. doi: 10.1111/j.1600-0447.1987.tb02831.x.
2
Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.早发型和晚发型阿尔茨海默病痴呆患者脑脊液中的单胺代谢产物及行为评分
Alzheimer Dis Assoc Disord. 1989 Fall;3(3):148-56. doi: 10.1097/00002093-198903030-00004.
3
CSF monoamine metabolites in old age dementias.
Mol Chem Neuropathol. 1992 Feb-Apr;16(1-2):143-57. doi: 10.1007/BF03159966.
4
[Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].[采用高效液相色谱-电化学检测法测定脑脊液中单胺类及单胺代谢产物的浓度]
No To Shinkei. 1982 Nov;34(11):1099-106.
5
Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.司来吉兰对阿尔茨海默病患者脑脊液单胺代谢产物的剂量依赖性效应。
Psychopharmacology (Berl). 1987;91(3):293-6. doi: 10.1007/BF00518180.
6
Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection.采用高效液相色谱-电化学检测法同时测定脑脊液中的3-甲氧基-4-羟基苯乙二醇、5-羟吲哚乙酸和高香草酸。
Anal Biochem. 1983 May;131(1):246-53. doi: 10.1016/0003-2697(83)90162-8.
7
Analysis of monoamines in the cerebrospinal fluid of Chinese patients with Alzheimer's disease.中国阿尔茨海默病患者脑脊液中单胺类物质的分析。
Ann N Y Acad Sci. 1991;640:215-8. doi: 10.1111/j.1749-6632.1991.tb00220.x.
8
Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.经组织学证实的阿尔茨海默病痴呆患者腰椎脑脊液中的单胺代谢物浓度。
J Neurol Neurosurg Psychiatry. 1984 May;47(5):481-4. doi: 10.1136/jnnp.47.5.481.
9
[Effects of idebenone on monoamine metabolites in the cerebrospinal fluid of patients with cerebrovascular dementia].
No To Shinkei. 1986 Feb;38(2):187-93.
10
Simultaneous determination of the three major monoamine metabolites in cerebrospinal fluid by high-performance liquid chromatography with electrochemical detection.
J Chromatogr. 1983 Jun 10;275(1):11-20. doi: 10.1016/s0378-4347(00)84339-x.

引用本文的文献

1
Experiences and Perspectives of GC-MS Application for the Search of Low Molecular Weight Discriminants of Schizophrenia.GC-MS 应用于寻找精神分裂症低分子量标志物的经验和观点。
Molecules. 2022 Dec 31;28(1):324. doi: 10.3390/molecules28010324.
2
Increased CSF HVA response to arecoline challenge in Alzheimer's disease.阿尔茨海默病中脑脊液高香草酸对槟榔碱激发试验的反应增强。
J Neural Transm Gen Sect. 1992;90(1):53-65. doi: 10.1007/BF01250518.